Retraction

Correlations between peroxisome proliferator activator receptor gamma, Cystatin C, or advanced oxidation protein product, and atherosclerosis in diabetes patients

Retraction Details

Citations (4)

4
Total Citations
3
Post-Retraction
(75.0%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
3 After 2+ years
2637 Days since retraction (latest)
Paper citing Correlations between peroxisome proliferator activ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing VCAM-1-targeted and PPARδ-agonist-loaded nano mice...
Unknown Authors
Unknown Journal
Published: Jul 2023
2637 days after retraction
Paper citing Correlations between peroxisome proliferator activ...
Unknown Authors
Unknown Journal
Published: Mar 2023
2515 days after retraction
Paper citing Correlations between peroxisome proliferator activ...
Unknown Authors
Unknown Journal
Published: Oct 2022
2380 days after retraction
Quick Stats
Total Citations: 4
Years Since Retraction: 9.6 years
Open Access: Yes
Last Checked: Never
Related Papers
The pathogenicity of COVID-19 and the role of pentraxin-3: …
Pathology: Research and Practice • 10 citations
Long noncoding RNA LBX2-AS1 drives the progression of hepat…
Pathology: Research and Practice • 14 citations
Serine/threonine kinase BUB1 promotes proliferation and rad…
Pathology: Research and Practice • 24 citations
Diagnostic performance of MASP-2 in the diagnosis of colore…
Pathology: Research and Practice • 0 citations
LINC00342 promotes thyroid carcinoma progression by targeti…
Pathology: Research and Practice • 1 citations